Charles Schwab Investment Management »

Aardvark Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $189k 14k 13.29
2025-06-30 $193k 14k 13.52

More positions owned by Charles Schwab Investment Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Schwab Strategic Tr Fundamental Intl (FNDF)
Abbvie (ABBV)
JPMorgan Chase & Co. (JPM)
Home Depot (HD)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)

View all positions for Charles Schwab Investment Management

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
Vanguard Group
Adage Capital Partners GP
Millennium Management
BlackRock
Silverarc Capital Management
Schonfeld Strategic Advisors
Geode Capital Management
Cresset Asset Management
Cantor Fitzgerald, L. P.
State Street Corporation
Two Sigma Investments
Northern Trust

View all funds holding Aardvark Therapeutics